A precision medicine–based strategy for a severe adverse drug reaction
- 3 February 2020
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 26 (2), 167-168
- https://doi.org/10.1038/s41591-020-0756-0
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Targeted therapy guided by single-cell transcriptomic analysis in drug-induced hypersensitivity syndrome: a case reportNature Medicine, 2020
- Drug-induced hypersensitivity syndrome with myocardial involvement treated with tofacitinibJAAD Case Reports, 2019
- An Updated Review of the Molecular Mechanisms in Drug HypersensitivityJournal of Immunology Research, 2018
- Treatments for Severe Cutaneous Adverse ReactionsJournal of Immunology Research, 2017
- Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): An Interplay among Drugs, Viruses, and Immune SystemInternational Journal of Molecular Sciences, 2017
- Epidemiology of cutaneous adverse drug reactionsAllergologie, 2017
- Preferential expression of CD134, an HHV-6 cellular receptor, on CD4T cells in drug-induced hypersensitivity syndrome (DIHS)/drug reaction with eosinophilia and systemic symptoms (DRESS)Journal of Dermatological Science, 2016
- Clinical and economic burden of adverse drug reactionsJournal of Pharmacology and Pharmacotherapeutics, 2013
- Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?British Journal of Dermatology, 2007